Kolexia
Danu Alina Hématologie
Danu Alina
Hématologie
Gustave-Roussy
Villejuif, France
77 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Maladie de Hodgkin Lymphome B Lymphome B diffus à grandes cellules Lymphome malin non hodgkinien Myélome multiple Récidive tumorale locale Leucémies Leucémie aigüe myéloïde

Collaborateurs

Voir plus
Lazarovici Julien
Lazarovici Julien
Ch Prive De L Europe, Le Port-Marly, France
Ghez David
Ghez David
Gustave-Roussy, Villejuif, France
Ribrag Vincent
Ribrag Vincent
Gustave-Roussy, Villejuif, France
Michot Jean-Marie
Michot Jean-Marie
Gustave-Roussy, Villejuif, France

Industries

Voir plus
Amgen
6 collaboration(s)
Dernière en 2023
Janssen
3 collaboration(s)
Dernière en 2022
Abbvie
1 collaboration(s)
Dernière en 2023
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
KarMMa-9: A Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation (KarMMa-9)
Essai Clinique (BMS)   18 mars 2024
Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study.
Leukemia & lymphoma   03 mars 2024
An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread: A Phase 1/2 First-in-Human Study of BMS-986258 Alone and in Combination With Nivolumab in Advanced Malignant Tumors
Essai Clinique (BMS)   27 septembre 2023
When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes.
EJHaem   19 mai 2023
Incidence, characteristics, management and outcome of patients with follicular lymphoma with tumor epidural compression, a study on 22 cases.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   06 mai 2023
A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies: A Phase 1/2a Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody (Relatlimab, BMS-986016) Administered Alone and in Combination With Anti-PD-1 Monoclonal Antibody (Nivolumab, BMS-936558) in Relapsed or Refractory B-Cell Malignancies
Essai Clinique (BMS)   20 mars 2023
Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study.
Cancers   28 février 2023
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.
American journal of hematology   18 janvier 2023
Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma.
Haematologica   01 août 2022
Molecular Profiling Feasibility on Cell-Free Tumoral DNA in Relapse/Refractory (R/R) Multiple Myeloma (MM) Patients Screened for Phase I Trials
Blood   23 novembre 2021